Sera Prognostics SERA Stock
Sera Prognostics Price Chart
Sera Prognostics SERA Financial and Trading Overview
| Sera Prognostics stock price | 9.66 USD |
| Previous Close | 3.31 USD |
| Open | 3.47 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1100 |
| Day's Range | 3.3 - 3.5 USD |
| 52 Week Range | 1.1 - 4.25 USD |
| Volume | 35.78K USD |
| Avg. Volume | 37.95K USD |
| Market Cap | 106.2M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.75 USD |
SERA Valuation Measures
| Enterprise Value | 34.58M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.3265307 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 321.81268 |
| Price/Book (mrq) | 1.176066 |
| Enterprise Value/Revenue | 104.783 |
| Enterprise Value/EBITDA | -0.798 |
Trading Information
Sera Prognostics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 169.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.25 USD |
| 52 Week Low | 1.1 USD |
| 50-Day Moving Average | 3.39 USD |
| 200-Day Moving Average | 2.35 USD |
SERA Share Statistics
| Avg. Volume (3 month) | 37.95K USD |
| Avg. Daily Volume (10-Days) | 30.49K USD |
| Shares Outstanding | 29.65M |
| Float | 17.63M |
| Short Ratio | 7.41 |
| % Held by Insiders | 15.76% |
| % Held by Institutions | 48.13% |
| Shares Short | 148.22K |
| Short % of Float | 0.64% |
| Short % of Shares Outstanding | 0.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -13388.18% |
| Gross Margin | 28.78% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.96% |
| Return on Equity (ttm) | -39.13% |
Income Statement
| Revenue (ttm) | 330K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | 163.19% |
| Gross Profit (ttm) | 75K USD |
| EBITDA | -43353000 USD |
| Net Income Avi to Common (ttm) | -42543000 USD |
| Diluted EPS (ttm) | -1.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 70.79M USD |
| Total Cash Per Share (mrq) | 2.28 USD |
| Total Debt (mrq) | 2.58M USD |
| Total Debt/Equity (mrq) | 2.86 USD |
| Current Ratio (mrq) | 5.225 |
| Book Value Per Share (mrq) | 2.908 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -29934000 USD |
| Levered Free Cash Flow (ttm) | -15246750 USD |
Profile of Sera Prognostics
| Country | United States |
| State | UT |
| City | Salt Lake City |
| Address | 2749 East Parleys Way |
| ZIP | 84109 |
| Phone | 801-990-0520 |
| Website | https://seraprognostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 87 |
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Q&A For Sera Prognostics Stock
What is a current SERA stock price?
Sera Prognostics SERA stock price today per share is 9.66 USD.
How to purchase Sera Prognostics stock?
You can buy SERA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sera Prognostics?
The stock symbol or ticker of Sera Prognostics is SERA.
Which industry does the Sera Prognostics company belong to?
The Sera Prognostics industry is Diagnostics & Research.
How many shares does Sera Prognostics have in circulation?
The max supply of Sera Prognostics shares is 32.43M.
What is Sera Prognostics Price to Earnings Ratio (PE Ratio)?
Sera Prognostics PE Ratio is now.
What was Sera Prognostics earnings per share over the trailing 12 months (TTM)?
Sera Prognostics EPS is -1.16 USD over the trailing 12 months.
Which sector does the Sera Prognostics company belong to?
The Sera Prognostics sector is Healthcare.
Sera Prognostics SERA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}